Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F R Appelbaum

Showing results (451-460 of 490) with videos related to

Pageof 49
Sort By:
Blood|May 23, 2001
Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantationJ Storek, M A Dawson, B Storer, et al.
Blood|August 15, 1997
Marrow transplants from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemiaJ Sierra, J Radich, J A Hansen, et al.
Blood|December 9, 2000
Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group StudyM L Slovak, K J Kopecky, P A Cassileth, et al.
The New England Journal of Medicine|December 3, 1998
Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remissionP A Cassileth, D P Harrington, F R Appelbaum, et al.
Blood|January 7, 1998
Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host diseaseJ Storek, T Gooley, M Siadak, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 5, 1998
High-dose busulfan, melphalan, and thiotepa followed by autologous peripheral blood stem cell transplantation in patients with aggressive lymphoma or relapsed Hodgkin's diseaseK Schiffman, C D Buckner, R Maziarz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 25, 2000
Granulocyte colony-stimulating factor given to donors before apheresis does not prevent aplasia in patients treated with donor leukocyte infusion for recurrent chronic myeloid leukemia after bone marrow transplantationM E Flowers, W Leisenring, K Beach, et al.
Bone Marrow Transplantation|April 21, 2009
Therapy with mycophenolate mofetil for refractory acute and chronic GVHDT Furlong, P Martin, M E D Flowers, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 1998
Safeguarding the administration of high-dose chemotherapy: a national practice survey by the American Society for Blood and Marrow TransplantationC S Chen, K Seidel, J O Armitage, et al.
Leukemia|May 21, 2010
Comparison of matched unrelated and matched related donor myeloablative hematopoietic cell transplantation for adults with acute myeloid leukemia in first remissionR B Walter, J M Pagel, T A Gooley, et al.
Pageof 49

Showing results (451-460 of 490) with videos related to

Sort By:
Pageof 49
Blood|May 23, 2001
Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantationJ Storek, M A Dawson, B Storer, et al.
Blood|August 15, 1997
Marrow transplants from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemiaJ Sierra, J Radich, J A Hansen, et al.
Blood|December 9, 2000
Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group StudyM L Slovak, K J Kopecky, P A Cassileth, et al.
The New England Journal of Medicine|December 3, 1998
Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remissionP A Cassileth, D P Harrington, F R Appelbaum, et al.
Blood|January 7, 1998
Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host diseaseJ Storek, T Gooley, M Siadak, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 5, 1998
High-dose busulfan, melphalan, and thiotepa followed by autologous peripheral blood stem cell transplantation in patients with aggressive lymphoma or relapsed Hodgkin's diseaseK Schiffman, C D Buckner, R Maziarz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 25, 2000
Granulocyte colony-stimulating factor given to donors before apheresis does not prevent aplasia in patients treated with donor leukocyte infusion for recurrent chronic myeloid leukemia after bone marrow transplantationM E Flowers, W Leisenring, K Beach, et al.
Bone Marrow Transplantation|April 21, 2009
Therapy with mycophenolate mofetil for refractory acute and chronic GVHDT Furlong, P Martin, M E D Flowers, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 1998
Safeguarding the administration of high-dose chemotherapy: a national practice survey by the American Society for Blood and Marrow TransplantationC S Chen, K Seidel, J O Armitage, et al.
Leukemia|May 21, 2010
Comparison of matched unrelated and matched related donor myeloablative hematopoietic cell transplantation for adults with acute myeloid leukemia in first remissionR B Walter, J M Pagel, T A Gooley, et al.
Pageof 49